CSGALNACT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.924400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.245160E-01
Normal-vs-Stage2
5.459400E-01
Normal-vs-Stage3
3.384000E-01
Normal-vs-Stage4
6.719800E-01
Stage1-vs-Stage2
3.212000E-01
Stage1-vs-Stage3
6.337600E-01
Stage1-vs-Stage4
6.220200E-02
Stage2-vs-Stage3
6.562600E-01
Stage2-vs-Stage4
1.770380E-01
Stage3-vs-Stage4
1.994230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.468800E-01
Normal-vs-AfricanAmerican
8.487800E-01
Normal-vs-Asian
3.337600E-01
Caucasian-vs-AfricanAmerican
4.670000E-01
Caucasian-vs-Asian
4.451200E-01
AfricanAmerican-vs-Asian
3.341600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.576000E-01
Normal-vs-Female
5.597800E-01
Male-vs-Female
4.903600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.283400E-01
Normal-vs-Age(41-60Yrs)
9.235800E-01
Normal-vs-Age(61-80Yrs)
3.603000E-01
Normal-vs-Age(81-100Yrs)
9.476200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.232400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.775600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.114000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.103700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.674500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.613600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.935570E-01
Normal-vs-Daily Drinker
1.172440E-01
Normal-vs-Weekly Drinker
5.853600E-01
Normal-vs-Occasional Drinker
5.423400E-01
Normal-vs-Social Drinker
8.120200E-01
Non Drinker-vs-Daily Drinker
5.503400E-01
Non Drinker-vs-Weekly Drinker
2.396800E-01
Non Drinker-vs-Occasional Drinker
3.161000E-01
Non Drinker-vs-Social Drinker
2.557800E-01
Daily Drinker-vs-Weekly Drinker
1.155010E-01
Daily Drinker-vs-Occasional Drinker
1.596620E-01
Daily Drinker-vs-Social Drinker
1.498620E-01
Weekly Drinker-vs-Occasional Drinker
8.660400E-01
Weekly Drinker-vs-Social Drinker
7.836800E-01
Occasional Drinker-vs-Social Drinker
6.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.854600E-01
Normal-vs-Grade 2
3.673900E-02
Normal-vs-Grade 3
7.850200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.783600E-03
Grade 1-vs-Grade 3
1.146190E-01
Grade 1-vs-Grade 4
2.854600E-01
Grade 2-vs-Grade 3
3.332800E-01
Grade 2-vs-Grade 4
3.673900E-02
Grade 3-vs-Grade 4
7.850200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.625200E-01
Normal-vs-NonDiabetic
3.474600E-01
Diabetic-vs-NonDiabetic
7.118800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.857900E-02
Normal-vs-NoPancreatitis
4.352600E-01
Pancreatitis-vs-NoPancreatitis
1.702780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.281600E-01
Normal-vs-N1
5.439400E-01
N0-vs-N1
3.198400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.718200E-01
Normal-vs-TP53-NonMutant
3.434400E-01
TP53-Mutant-vs-TP53-NonMutant
7.480400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
